Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 556–570 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2790
Oncomine Chronic Myelomonocytic Leukemia (CMML) Panel Test

This diagnostic test evaluates for somatic mutations in genes commonly associated with Chronic Myelomonocytic Leukemia (CMML).

Whole blood (3 mL, EDTA) OR bone marrow aspirate (2 mL) 2–4 weeks (batched 1st/16th of month) 4,600.00 AED
View
View test specifications and preparation
What it measures
["Somatic mutations in key genes associated with CMML", "Molecular profile for diagnosis and risk stratification"]
Parameters
[]
Preparation
["No dietary or drug restrictions.", "Disclose all anticoagulant and antiplatelet medications to the collecting clinician."]
Indications
["Confirmation of CMML diagnosis", "Risk stratification in CMML", "Personalized therapeutic planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103136-6 ICD-10: C93.10
Clinical summary
This diagnostic test evaluates for somatic mutations in genes commonly associated with Chronic Myelomonocytic Leukemia (CMML).
TEST-2764
Oncomine Comprehensive Myeloid Panel Test

This test evaluates DNA and RNA from blood or bone marrow to detect mutations, fusions, and gene expression changes relevant to myeloid malignancies.

Whole Blood (3 mL EDTA lavender top) or Bone Marrow Aspirate 15 days from batch date 5,000.00 AED
View
View test specifications and preparation
What it measures
["Mutations in over 40 genes (e.g., FLT3, NPM1, IDH1/2, BCR-ABL1)", "Gene fusions", "Gene expression changes"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Diagnosis of acute myeloid leukemia (AML)", "Diagnosis of myelodysplastic syndromes (MDS)", "Prognosis assessment in myeloid neoplasms", "Personalized therapy selection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101328-7 ICD-10: C92.00
Clinical summary
This test evaluates DNA and RNA from blood or bone marrow to detect mutations, fusions, and gene expression changes relevant to myeloid malignancies.
TEST-1267
Oncomine Comprehensive Panel + Tumor Mutation Burden (TMB) + Microsatellite Instability (MSI) + PD-L1 (IHC) Test

This test evaluates hundreds of cancer-related genes, tumor mutational burden, microsatellite instability, and PD-L1 expression using NGS and IHC.

Tumor tissue (formalin-fixed paraffin-embedded block or unstained slides) and peripheral whole blood 14–21 business days 16,000.00 AED
View
View test specifications and preparation
What it measures
["Somatic mutations in >500 genes", "Tumor Mutation Burden (TMB)", "Microsatellite Instability (MSI)", "PD-L1 expression (IHC)"]
Parameters
[{"name": "Tumor Mutation Burden (TMB)", "reference_range": null}, {"name": "Microsatellite Instability (MSI)", "reference_range": null}, {"name": "PD-L1 Expression", "reference_range": null}, {"name": "Somatic Mutations", "reference_range": null}]
Preparation
["A valid prescription from a DHA-licensed physician is required.", "Ensure sufficient tumor tissue is available."]
Indications
["Guiding targeted therapy selection", "Determining immunotherapy eligibility", "Assessing hereditary cancer risk", "Monitoring treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101661-5 ICD-10: Z15.09, Z15.01, Z15.02
Clinical summary
This test evaluates hundreds of cancer-related genes, tumor mutational burden, microsatellite instability, and PD-L1 expression using NGS and IHC.
TEST-1275
Oncomine Comprehensive Panel + Tumor Mutation Burden + MSI Test

This test evaluates hundreds of cancer-related genes, tumor mutational burden (TMB), and microsatellite instability (MSI) status using next-generation sequencing.

Tumor tissue (FFPE block or fresh biopsy) + Matched peripheral whole blood 14–21 calendar days from specimen receipt 14,000.00 AED
View
View test specifications and preparation
What it measures
["Single-nucleotide variants", "Insertions and deletions", "Copy number alterations", "Gene fusions", "Tumor Mutational Burden (TMB)", "Microsatellite Instability (MSI)", "Somatic vs. Germline mutations"]
Parameters
[]
Preparation
[]
Indications
["Advanced or metastatic solid tumors", "Exhausted standard treatment options", "Seeking personalized oncology approaches"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91847-6 ICD-10: C80.1, Z85.9
Clinical summary
This test evaluates hundreds of cancer-related genes, tumor mutational burden (TMB), and microsatellite instability (MSI) status using next-generation sequencing.
TEST-1263
Oncomine Comprehensive Plus Panel Test

This test performs comprehensive genomic profiling on solid tumor tissue to identify actionable mutations and biomarkers relevant to cancer treatment.

FFPE tumor tissue block or 10 unstained slides (archival tissue specimen) 2–3 weeks (14–21 calendar days) 26,000.00 AED
View
View test specifications and preparation
What it measures
["Somatic mutations (SNVs, indels)", "Copy number variations (CNVs)", "Gene fusions", "Tumor mutational burden (TMB)", "Microsatellite instability (MSI)"]
Parameters
[]
Preparation
[]
Indications
["Patients diagnosed with advanced or rare solid tumors", "Seeking therapy guidance", "Hereditary cancer risk assessment", "Clinical trial eligibility assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81270-9 ICD-10: Z13.79
Clinical summary
This test performs comprehensive genomic profiling on solid tumor tissue to identify actionable mutations and biomarkers relevant to cancer treatment.
TEST-1253
Oncomine Myeloid Panel (MDS, MPN, AML, CML, CMML, JMML) Test

This diagnostic test evaluates DNA and RNA from bone marrow or peripheral blood to detect mutations, fusions, and gene expression profiles associated with myeloid malignancies.

Bone Marrow Aspirate (preferred) / Peripheral Blood (5 mL EDTA) 14–21 Business Days 5,000.00 AED
View
View test specifications and preparation
What it measures
["DNA mutations", "RNA fusions", "Gene expression profiles", "40+ genes", "29 fusion drivers"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of MDS, MPN, AML, CML, CMML, JMML", "Risk stratification in myeloid malignancies", "Guiding targeted therapy decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98557-3 ICD-10: C92.90, C93.90, C94.40, D46.9, D47.1
Clinical summary
This diagnostic test evaluates DNA and RNA from bone marrow or peripheral blood to detect mutations, fusions, and gene expression profiles associated with myeloid malignancies.
TEST-2799
Oncomine Myeloproliferative Neoplasm (MPN) Panel Test

This test identifies mutations in genes commonly associated with myeloproliferative neoplasms (MPNs) using Next-Generation Sequencing.

Whole blood or bone marrow (EDTA, refrigerated) Reports released by the 15th or 30th of the month 4,600.00 AED
View
View test specifications and preparation
What it measures
["Mutations in JAK2, CALR, MPL, ASXL1, EZH2, SRSF2, and other relevant genes", "Presence of driver and prognostic mutations in MPNs"]
Parameters
[]
Preparation
["No specific fasting required", "Inform your doctor about all medications you are taking"]
Indications
["Diagnosis of suspected myeloproliferative neoplasms (MPNs)", "Subtyping of MPNs (e.g., Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis)", "Prognostic assessment in MPNs", "Guiding targeted therapy selection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92197-1 ICD-10: D47.1
Clinical summary
This test identifies mutations in genes commonly associated with myeloproliferative neoplasms (MPNs) using Next-Generation Sequencing.
TEST-1250
Oncomine Tumor Mutation Burden (TMB) & Microsatellite Instability (MSI) Analysis Test

This test evaluates tumor mutational burden (TMB) and microsatellite instability (MSI) status using next-generation sequencing and Sanger confirmation.

Tumor tissue (biopsy / resection) and peripheral blood 2–3 weeks 7,000.00 AED
View
View test specifications and preparation
What it measures
["Tumor Mutational Burden (TMB)", "Microsatellite Instability (MSI)"]
Parameters
[{"name": "TMB", "reference_range": null}, {"name": "MSI Status", "reference_range": null}]
Preparation
[]
Indications
["Guiding immunotherapy decisions", "Guiding targeted therapy decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96317-7, 94520-1 ICD-10: C80.1, Z85.9
Clinical summary
This test evaluates tumor mutational burden (TMB) and microsatellite instability (MSI) status using next-generation sequencing and Sanger confirmation.
TEST-1262
Oncomine Tumor Mutation Burden (TMB) Analysis Test

This test quantifies the total number of somatic mutations per megabase in a tumor sample using next-generation sequencing.

Archived Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Blocks or Unstained Slides 14 – 21 Business Days 5,600.00 AED
View
View test specifications and preparation
What it measures
["Total somatic mutations per megabase", "Neoantigen burden (indirectly)"]
Parameters
[]
Preparation
[]
Indications
["Predicting response to immune checkpoint inhibitors", "Guiding immuno-oncology treatment decisions", "Solid tumor analysis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96359-1 ICD-10: Z51.1, C80.1
Clinical summary
This test quantifies the total number of somatic mutations per megabase in a tumor sample using next-generation sequencing.
TEST-1279
Oncomineβ„’ Comprehensive Assay Test

This test analyzes 143 cancer-associated genes in tumor tissue using Next-Generation Sequencing (NGS) to identify actionable genomic alterations.

Tumour tissue (FFPE/fresh) 2–3 weeks 7,600.00 AED
View
View test specifications and preparation
What it measures
["Single Nucleotide Variants (SNVs)", "Copy Number Variations (CNVs)", "Gene Fusions"]
Parameters
[]
Preparation
[]
Indications
["Guiding personalized oncologic therapy", "Detecting targetable mutations in solid tumors", "Matching patients with approved targeted therapies or clinical trials"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 85252-0 ICD-10: C80.1, Z15.01, Z15.09
Clinical summary
This test analyzes 143 cancer-associated genes in tumor tissue using Next-Generation Sequencing (NGS) to identify actionable genomic alterations.
TEST-1266
Oncomineβ„’ Lung cfTNA Cancer Panel (Liquid Biopsy) Test

This test detects genetic alterations in cell-free tumor DNA from blood to guide lung cancer treatment.

10 mL peripheral blood (cfTNA) 14–21 business days 7,000.00 AED
View
View test specifications and preparation
What it measures
["Single-nucleotide variants", "Insertions/deletions", "Copy-number changes", "Gene fusions", "Cell-free total nucleic acid (cfTNA)"]
Parameters
[]
Preparation
["No fasting or special preparation is required"]
Indications
["Patients with suspected or confirmed non-small cell lung cancer (NSCLC)", "Patients for whom tissue biopsy is medically risky", "Guiding first-line targeted therapy", "Tracking resistance mechanisms", "Serial disease surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94574-2 ICD-10: C34.90
Clinical summary
This test detects genetic alterations in cell-free tumor DNA from blood to guide lung cancer treatment.
TEST-2768
Oncomineβ„’ Myelodysplastic Syndrome (MDS) Panel Test

This diagnostic test evaluates for somatic mutations in genes commonly associated with myelodysplastic syndromes (MDS) using next-generation sequencing.

EDTA whole blood (preferred) or bone marrow aspirate 15–30 days 4,600.00 AED
View
View test specifications and preparation
What it measures
["Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Splice site mutations", "Variant allele frequency (VAF)"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform physician about current medications."]
Indications
["Diagnosis of suspected MDS", "Risk stratification in confirmed MDS", "Guidance for targeted or epigenetic therapy selection", "Monitoring for clonal evolution"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98591-2 ICD-10: D46.9
Clinical summary
This diagnostic test evaluates for somatic mutations in genes commonly associated with myelodysplastic syndromes (MDS) using next-generation sequencing.
TEST-2771
ONCOPRO 350 GENE TMB & MSI PROFILE Test

This test evaluates 350 cancer-related genes, Tumor Mutational Burden (TMB), and Microsatellite Instability (MSI) status using Next-Generation Sequencing (NGS). It provides a compr...

FFPE Tissue Block / Biopsy Slides (Archival Specimen) 45 Working Days 7,800.00 AED
View
View test specifications and preparation
What it measures
["350 Cancer-Related Genes", "Tumor Mutational Burden (TMB)", "Microsatellite Instability (MSI)"]
Parameters
[]
Preparation
[]
Indications
["Guiding immunotherapy selection", "Guiding targeted therapy selection", "Comprehensive genomic profiling of tumors"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91850-2 ICD-10: Z85.9
Clinical summary
This test evaluates 350 cancer-related genes, Tumor Mutational Burden (TMB), and Microsatellite Instability (MSI) status using Next-Generation Sequencing (NGS). It provides a comprehensive genomic profile to guide precision oncology treatment decisions.
TEST-53
OncoPro Colorectal Cancer Screening Test (Circulating Tumor Cells)

This test detects and quantifies circulating tumor cells (CTCs) in a blood sample.

Whole blood (special preservative tube provided in kit) 21 Working Days 4,200.00 AED
View
View test specifications and preparation
What it measures
["Circulating Tumor Cells (CTCs)", "EpCAM expression", "Cytokeratin (CK) expression", "CD45 expression", "DAPI staining"]
Parameters
[{"name": "Circulating Tumor Cells (CTCs)", "reference_range": "Negative (or specific quantitative range if applicable)"}]
Preparation
["Use the special preservative-added EDTA tube provided in the kit", "Ship sample immediately at 18–22Β°C", "Do not refrigerate or freeze the sample"]
Indications
["Early risk assessment for colorectal cancer", "Screening in high-risk individuals", "Complementary diagnostic tool"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 7549-9 ICD-10: C18.9
Clinical summary
This test detects and quantifies circulating tumor cells (CTCs) in a blood sample.
TEST-2807
ONCOPRO EGFR ARMS PCR Test

This test detects specific mutations in the EGFR gene within FFPE tumour tissue, guiding targeted therapy selection for non-small-cell lung cancer.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block 4 working days (sample received by Monday 11:00 AM) 1,300.00 AED
View
View test specifications and preparation
What it measures
["EGFR gene mutations (exon 19 deletions, L858R, T790M, C797S)", "Allele frequency"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of non-small-cell lung cancer (NSCLC)", "Selection of targeted therapy (TKI) for NSCLC", "Monitoring for resistance mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82989-2 ICD-10: C34.90
Clinical summary
This test detects specific mutations in the EGFR gene within FFPE tumour tissue, guiding targeted therapy selection for non-small-cell lung cancer.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area